Assessing the performance of Coenzyme Q10 loaded DQAsomes to treat Leigh syndrome caused by NDUFS4 knockout
Küçük Resim Yok
Tarih
2024
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Editions de Sante
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Homozygous mutations in the NDUFS4 gene result in one of the many autosomal recessive forms of Leigh syndrome (LS), which impairs mitochondrial complex I function. In time, this disorder results in mental and motor impairment, often resulting in death. LS has no cure, and treatment focuses on symptom management. The delivery of CoQ10 can be improved in treating LS when caused by mutations in the NDUFS4 gene. Its poor solubility and bioavailability limit its clinical use as a preventative for oxidative damage and mitochondrial function. In this study, we developed CoQ10-loaded DQAsomes, utilizing dequalinium chloride -a bolalipid known for its antimicrobial properties to improve mitochondrial delivery of CoQ10. These DQAsomes were evaluated in an NDUFS4 knockout mouse model. Mitochondria from lung tissue of 32 knock-out mice and matched controls were isolated and CoQ10 uptake was quantified using fluorescence microscopy. Mitochondrial proteins were measured through ELISA, Western Blot, and PCR, and histopathological examination was performed to support the findings. The DQAsomes were measured to be approximately 151.3 nm with a polydispersity index (PDI) of 0.181, and mitochondrial uptake was found to be around 91.2 %. The apoptosis score measured following pure-CoQ10 administration was found to be 5.5 times higher compared to DQAsomes, while the inflammation score measured following DQAsomes administration was found to be 6.2 times lower than pure-CoQ10. Overall, these findings suggest promising therapeutic potential for DQAsomes in LS management, emphasizing their role in targeted mitochondrial CoQ10 delivery and potential clinical application. © 2024
Açıklama
Anahtar Kelimeler
Coenzyme Q10; Dequalinium Chloride; Knockout Mice; Leigh Disease; Mitochondrial Targeting, Dequalinium; Mitochondrial Protein; Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone); Ubidecarenone; Animal Experiment; Animal Model; Animal Tissue; Antimicrobial Activity; Apoptosis; Article; Controlled Study; Dispersity; Enzyme Linked Immunosorbent Assay; Fluorescence Microscopy; Histopathology; Human; Inflammation; Knockout Mouse; Leigh Disease; Lung Parenchyma; Male; Mitochondrion; Motor Dysfunction; Mouse; Nonhuman; Western Blotting
Kaynak
Journal of Drug Delivery Science and Technology
WoS Q Değeri
Scopus Q Değeri
Q1
Cilt
97
